Last edition
News about "World Health Organization (WHO)"
Experts Highlight Need for AI-Based Quality and Traceability in Medicinal Plants
Experts at a national seminar hosted by IIT Delhi emphasised the need for AI-enabled farm-gate quality assessment and traceability to strengthen India’s medicinal plant supply chain, outlining a digital roadmap to enhance the global competitiveness of AYUSH raw materials.
World Health Organization (WHO) | 13/01/2026 | By News Bureau
Biofabri and Bharat Biotech Sign Technology Transfer Deal for MTBVAC
Biofabri and Bharat Biotech have entered into a technology transfer agreement to enable end-to-end manufacturing of the MTBVAC tuberculosis vaccine candidate, supporting global efforts to expand access to new TB prevention options, particularly in high-burden, low- and middle-income countries.
World Health Organization (WHO) | 24/12/2025 | By News Bureau
WHO Issues First Global Guideline on GLP-1 Therapies for Obesity
To tackle the growing global health challenge of obesity—which now affects more than one billion people worldwide—the World Health Organization (WHO) has released its first guideline on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for treating obesity as a chronic, relapsing disease.
World Health Organization (WHO) | 03/12/2025 | By Darshana
WHO Issues Alert Over Contaminated Oral Liquid Medicines from India
The World Health Organization (WHO) has issued a Medical Product Alert following the identification of three substandard (contaminated) oral liquid medicines in India.
World Health Organization (WHO) | 14/10/2025 | By Dineshwori | 333
WHO Warns of Insufficient Pipeline of Treatments and Diagnostics to Combat Antimicrobial Resistance
The World Health Organization (WHO) has raised the alarm over the shrinking pipeline of new antibacterials and diagnostics, urging greater investment in R&D to tackle the growing threat of antimicrobial resistance (AMR).
World Health Organization (WHO) | 03/10/2025 | By Dineshwori | 377
Coronavirus: WHO stops trial of hydroxycloroquine due to safety concerns
The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday
World Health Organization (WHO) | 26/05/2020 | By Darshana | 457
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy